Wolfe M M, Reel G M, McGuigan J E
J Clin Invest. 1983 Nov;72(5):1586-93. doi: 10.1172/JCI111117.
Somatostatin-containing cells have been shown to be in close anatomic proximity to gastrin-producing cells in rat antral mucosa. The present studies were directed to examine the effect of secretin on carbachol-stimulated gastrin release and to assess the potential role of somatostatin in mediating this effect. Rat antral mucosa was cultured at 37 degrees C in Krebs-Henseleit buffer, pH 7.4, gassed with 95% O2-5% CO2. After 1 h the culture medium was decanted and mucosal gastrin and somatostatin were extracted. Carbachol (2.5 X 10(-6) M) in the culture medium increased gastrin level in the medium from 14.1 +/- 2.5 to 26.9 +/- 3.0 ng/mg tissue protein (P less than 0.02), and decreased somatostatin-like immunoreactivity in the medium from 1.91 +/- 0.28 to 0.62 +/- 0.12 ng/mg (P less than 0.01) and extracted mucosal somatostatin-like immunoreactivity from 2.60 +/- 0.30 to 1.52 +/- 0.16 ng/mg (P less than 0.001). Rat antral mucosa was then cultured in the presence of secretin to determine its effect on carbachol-stimulated gastrin release. Inclusion of secretin (10(-9)-10(-7) M) inhibited significantly carbachol-stimulated gastrin release into the medium, decreasing gastrin from 26.9 +/- 3.0 to 13.6 +/- 3.2 ng/mg (10(-9) M secretin) (P less than 0.05), to 11.9 +/- 1.7 ng/mg (10(-8) secretin) (P less than 0.02), and to 10.8 +/- 4.0 ng/mg (10(-7) M secretin) (P less than 0.02). Secretin (10(-7) and 10(-8) M) also increased concomitantly culture medium somatostatin concentration. To determine whether secretion inhibition of carbachol-stimulated gastrin release was mediated by somatostatin, antral mucosa was cultured with carbachol, secretin (10(-9)-10(-7) M), and antibodies to somatostatin. Inclusion of somatostatin antibodies in the culture medium abolished the capacity of secretin (10(-7) and 10(-8) M) to inhibit carbachol-stimulated gastrin release. Results of these studies indicate (a) that secretin inhibits carbachol-stimulated gastrin release and (b) that under the conditions of these experiments secretin inhibition of gastrin release is mediated, at least in part, locally through release of antral somatostatin.
已证明含生长抑素的细胞在大鼠胃窦黏膜中与产生胃泌素的细胞在解剖位置上紧密相邻。本研究旨在探讨促胰液素对卡巴胆碱刺激的胃泌素释放的影响,并评估生长抑素在介导此效应中的潜在作用。大鼠胃窦黏膜在37℃下于pH 7.4的克雷布斯 - 亨氏缓冲液中培养,用95% O₂ - 5% CO₂ 通气。1小时后倾析培养基,提取黏膜中的胃泌素和生长抑素。培养基中的卡巴胆碱(2.5×10⁻⁶ M)使培养基中的胃泌素水平从14.1±2.5 ng/mg组织蛋白增加到26.9±3.0 ng/mg(P<0.02),并使培养基中生长抑素样免疫反应性从1.91±0.28 ng/mg降低到0.62±0.12 ng/mg(P<0.01),同时提取的黏膜生长抑素样免疫反应性从2.60±0.30 ng/mg降低到1.52±0.16 ng/mg(P<0.001)。然后在促胰液素存在的情况下培养大鼠胃窦黏膜,以确定其对卡巴胆碱刺激的胃泌素释放的影响。加入促胰液素(10⁻⁹ - 10⁻⁷ M)可显著抑制卡巴胆碱刺激的胃泌素释放到培养基中,使胃泌素从26.9±3.0 ng/mg降至13.6±3.2 ng/mg(10⁻⁹ M促胰液素)(P<0.05),降至11.9±1.7 ng/mg(10⁻⁸ M促胰液素)(P<0.02),并降至10.8±4.0 ng/mg(10⁻⁷ M促胰液素)(P<0.02)。促胰液素(10⁻⁷和10⁻⁸ M)还同时增加了培养基中生长抑素的浓度。为了确定促胰液素对卡巴胆碱刺激的胃泌素释放的抑制作用是否由生长抑素介导,将胃窦黏膜与卡巴胆碱、促胰液素(10⁻⁹ - 10⁻⁷ M)和生长抑素抗体一起培养。培养基中加入生长抑素抗体消除了促胰液素(10⁻⁷和10⁻⁸ M)抑制卡巴胆碱刺激的胃泌素释放的能力。这些研究结果表明:(a)促胰液素抑制卡巴胆碱刺激的胃泌素释放;(b)在这些实验条件下,促胰液素对胃泌素释放至少部分是通过局部释放胃窦生长抑素来介导的。